Simultaneous acquisition sequence for improved hepatic pharmacokinetics quantification accuracy (SAHA) for dynamic contrast‐enhanced MRI of liver

Purpose To propose a simultaneous acquisition sequence for improved hepatic pharmacokinetics quantification accuracy (SAHA) method for liver dynamic contrast‐enhanced MRI. Methods The proposed SAHA simultaneously acquired high temporal‐resolution 2D images for vascular input function extraction usin...

Full description

Saved in:
Bibliographic Details
Published inMagnetic resonance in medicine Vol. 79; no. 5; pp. 2629 - 2641
Main Authors Ning, Jia, Sun, Yongliang, Xie, Sheng, Zhang, Bida, Huang, Feng, Koken, Peter, Smink, Jouke, Yuan, Chun, Chen, Huijun
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.05.2018
Subjects
Online AccessGet full text
ISSN0740-3194
1522-2594
1522-2594
DOI10.1002/mrm.26915

Cover

More Information
Summary:Purpose To propose a simultaneous acquisition sequence for improved hepatic pharmacokinetics quantification accuracy (SAHA) method for liver dynamic contrast‐enhanced MRI. Methods The proposed SAHA simultaneously acquired high temporal‐resolution 2D images for vascular input function extraction using Cartesian sampling and 3D large‐coverage high spatial‐resolution liver dynamic contrast‐enhanced images using golden angle stack‐of‐stars acquisition in an interleaved way. Simulations were conducted to investigate the accuracy of SAHA in pharmacokinetic analysis. A healthy volunteer and three patients with cirrhosis or hepatocellular carcinoma were included in the study to investigate the feasibility of SAHA in vivo. Results Simulation studies showed that SAHA can provide closer results to the true values and lower root mean square error of estimated pharmacokinetic parameters in all of the tested scenarios. The in vivo scans of subjects provided fair image quality of both 2D images for arterial input function and portal venous input function and 3D whole liver images. The in vivo fitting results showed that the perfusion parameters of healthy liver were significantly different from those of cirrhotic liver and HCC. Conclusions The proposed SAHA can provide improved accuracy in pharmacokinetic modeling and is feasible in human liver dynamic contrast‐enhanced MRI, suggesting that SAHA is a potential tool for liver dynamic contrast‐enhanced MRI. Magn Reson Med 79:2629–2641, 2018. © 2017 International Society for Magnetic Resonance in Medicine.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0740-3194
1522-2594
1522-2594
DOI:10.1002/mrm.26915